Viridian Therapeutics Inc (VRDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 176,346 | 212,382 | 169,647 | 117,324 | 116,215 |
| Marketable Securities | 585,835 | 662,270 | 321,254 | 446,032 | 520,418 |
| Other current assets | 0 | 0 | 70,000 | 0 | 0 |
| TOTAL | $784,744 | $894,233 | $571,913 | $578,750 | $657,238 |
| Non-Current Assets | |||||
| PPE Net | 1,130 | 1,228 | 1,125 | 1,091 | 1,162 |
| Other Non-Current Assets | 3,143 | 3,957 | 4,100 | 2,483 | 2,581 |
| TOTAL | $4,273 | $5,185 | $5,225 | $3,574 | $3,743 |
| Total Assets | $789,017 | $899,418 | $577,138 | $582,324 | $660,981 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 8,435 | N/A |
| Accounts payable and accrued liabilities | 13,313 | 8,683 | 10,063 | 8,518 | 3,886 |
| Accrued Expenses | 38,492 | 62,013 | 40,633 | 35,344 | 29,553 |
| TOTAL | $51,805 | $70,696 | $50,696 | $52,585 | $33,727 |
| Non-Current Liabilities | |||||
| Long Term Debt | 50,436 | 49,940 | 20,890 | 12,353 | 20,685 |
| Deferred Revenues | N/A | N/A | N/A | 288 | 288 |
| Other Non-Current Liabilities | 50,768 | 56,615 | 2,582 | 2,077 | 1,884 |
| TOTAL | $101,204 | $106,555 | $23,472 | $14,570 | $22,781 |
| Total Liabilities | $153,009 | $177,251 | $74,168 | $67,155 | $56,508 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 103,075 | 102,207 | 95,442 | 81,662 | 81,592 |
| Common Shares | 1,025 | 1,018 | 822 | 817 | 816 |
| Retained earnings | -1,443,359 | -1,338,458 | -1,218,103 | -1,183,504 | -1,082,769 |
| Other shareholders' equity | 131,498 | 132,503 | 189,248 | 188,954 | 189,130 |
| TOTAL | $636,008 | $722,167 | $502,970 | $515,169 | $604,473 |
| Total Liabilities And Equity | $789,017 | $899,418 | $577,138 | $582,324 | $660,981 |